| Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma B Yaseen, H Lopez, Z Taki, S Zafar, H Rosario, BA Abdi, S Vigneswaran, ... Rheumatology 59 (9), 2625-2636, 2020 | 36 | 2020 |
| Pathogenic activation of mesenchymal stem cells is induced by the disease microenvironment in systemic sclerosis Z Taki, E Gostjeva, W Thilly, B Yaseen, H Lopez, M Mirza, Z Hassuji, ... Arthritis & Rheumatology 72 (8), 1361-1374, 2020 | 28 | 2020 |
| Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts S Vigneswaran, JHV Rojas, L Garvey, S Taylor-Robinson, A Winston The Neuroradiology Journal 28 (6), 545-554, 2015 | 4 | 2015 |
| P232 Effectiveness of adalimumab biosimilar switching: real world data from a London rheumatology centre S Vigneswaran, M Galloway, S Hanlon, A Tynan, A Singh Rheumatology 59 (Supplement_2), keaa111. 226, 2020 | 1 | 2020 |
| P146 A phase II, randomised, double-blind, placebo-controlled trial exploring pharmacokinetics, safety and efficacy of intravenous factor XIII treatment in adults with systemic … A Leslie, S Vigneswaran, K Khan, V Ong, CP Denton Rheumatology 63 (Supplement_1), keae163. 185, 2024 | | 2024 |
| E080 Catheter-related venous thrombosis in patients with systemic sclerosis: a case series C Giacomassi, T Eldaw, S Vigneswaran, A Debres, C Denton, V Ong Rheumatology 62 (Supplement_2), kead104. 329, 2023 | | 2023 |
| Catheter-Related Venous Thrombosis in Patients with Systemic Sclerosis: A Case Series C Giacomassi, T Eldaw, S Vigneswaran, A Debres, C Denton, V Ong Rheumatology (United Kingdom), ii162-ii163, 2023 | | 2023 |
| OP0254 CHROMATIN CONFORMATION SIGNATURE ANALYSIS IN EARLY VS LATE SCLERODERMA PHENOTYPES M Galloway, E Hunter, A Akoulitchev, S Vigneswaran, B Abdi, C Denton, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 160-160, 2020 | | 2020 |
| Imaging tools in sarcoidosis S Vigneswaran, R Gonem, J Ma, A Singh Rheumatology 59 (5), 1182-1183, 2020 | | 2020 |
| EFFECTIVENESS OF ADALIMUMAB BIOSIMILAR SWITCHING: REAL WORLD DATA FROM A LONDON RHEUMATOLOGY CENTRE S Vigneswaran, M Galloway, S Hanlon, A Tynan, A Singh RHEUMATOLOGY 59, 107-107, 2020 | | 2020 |
| Novel Therapeutic Peptides Which Target CD206 Inhibit Macrophage Dependent Fibroblast Activation in Scleroderma BA Abdi, H Lopez, G Martin, C Garvin, J Jaynes, J Stanway, CP Denton, ... ARTHRITIS & RHEUMATOLOGY 70, 2018 | | 2018 |
| O17 Interleukin 31 promotes pathogenic mechanisms in scleroderma and induces skin fibrosis in mice N Arumalla, H Rosario, Z Taki, S Vigneswaran, C Denton, BA Abdi, ... Rheumatology 57 (suppl_3), key075. 199, 2018 | | 2018 |
